CYTK FY 2013 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$31M+305.5% YoY

Gross Profit

-$19M-61.3% margin

Operating Income

-$34M-110.6% margin

Net Income

-$34M-110.0% margin

EPS (Diluted)

$-1.24

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$83M

Total Liabilities

$29M

Stockholders' Equity

$54M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$8M	+305.5%
Gross Profit	-$19M	-$28M	+33.1%
Operating Income	-$34M	-$39M	+13.3%
Net Income	-$34M	-$42M	+19.1%